Clindamycin: Difference between revisions
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===General=== | ===General=== | ||
*150-450mg PO q6h | *PO: 150-450mg PO q6h | ||
*IV/IM: 600-2700 mg/day IV/IM divided q6-12h | |||
*Max: | *Max: | ||
**600 mg/dose | **IM: 600 mg/dose | ||
**4800 mg/day | **IV: 4800 mg/day | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 13:54, 7 March 2014
General
- Type:
- Dosage Forms: IM, IV, PO (150mg; 300mg)
- Common Trade Names: Cleocin
Adult Dosing
General
- PO: 150-450mg PO q6h
- IV/IM: 600-2700 mg/day IV/IM divided q6-12h
- Max:
- IM: 600 mg/dose
- IV: 4800 mg/day
Pediatric Dosing
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: